YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGCK8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,670
Award facts
- Contract value 100% obligated
- $1,670.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,670.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a regional prime vendor contractor supporting Department of Defense pharmaceutical supply needs worldwide through 2036.
As part of the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a critical supplier of diverse pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities globally. The company's extensive federal contracting history demonstrates consistent performance across multiple product categories and delivery orders, with recent activity showing substantial engagement with the Defense Logistics Agency's Medical Supply Chain division. This YF-VAX delivery order represents a routine pharmaceutical supply requirement supporting Department of Defense operational and immunization needs across its global medical infrastructure.
Quick answers
Who was awarded contract SPE2DR26FGCK8?
SPE2DR26FGCK8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FGCK8 worth?
The government has obligated $1,670 on SPE2DR26FGCK8.
Is contract SPE2DR26FGCK8 an order under another contract?
Yes. SPE2DR26FGCK8 is a delivery order under SPE2DR25D9301, an indefinite delivery contract.
Was contract SPE2DR26FGCK8 competed?
The extent of competition for SPE2DR26FGCK8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award